Medical Disclaimer: This data is for informational purposes only. Success rates are influenced by patient age, diagnosis, and treatment type. Do not use this data alone to choose a fertility clinic. Consult a board-certified reproductive endocrinologist.

CDC NASS 2022 685 ART cycles Texas

IVFMD-Irving

IVFMD-Irving reported a 46.7% overall live-birth rate across 685 ART cycles in Irving, Texas (CDC NASS 2022).

Irving, Texas · ZIP 75063 · Last reported: 2022

Clinic verdict · CDC NASS 2022

IVFMD-Irving's IVF live-birth rate for patients under 35 is 57.3%, 9 points above the national average of 48%. Compare it across age groups and against the state below, and remember age is the strongest driver of IVF success.

46.7% Overall live birth
57.3% Under 35
685 Cycles, 2022
48% National, under 35

Where IVFMD-Irving sits among U.S. clinics

Overall CDC live-birth-rate band, 406 reporting clinics

Total Cycles

685

Reported 2022

Overall Success Rate

46.7%

Live births per cycle

+11.3pp vs TX avg

Rate Under 35

57.3%

Peak fertility cohort

Single Embryo Transfer

57.3%

ASRM-aligned safety metric

SET adherence vs national reference

Single-embryo-transfer rate is an ASRM-aligned safety metric, higher SET reduces multi-pregnancy and OHSS risk.

IVFMD-Irving SET rate 57.3%
78% national reference

Share of transfers using one embryo only

Success Rates by Age Group

Using own eggs (fresh + frozen cycles). The CDC reports patients over 40 in two separate brackets, 41–42 and 43+, shown here individually rather than combined.

Under 35 57.3%
35–37 43.8%
38–40 22.0%
41–42 Not reported
43+ Not reported

Success rate = live births per ART cycle started. Source: CDC NASS 2022.

Cycle Breakdown

Total Cycles
685
Fresh Cycles
24
Frozen Cycles
661
Years Reporting
3
Single Embryo Transfer %
57.3%

Services Available

  • × Donor Egg Available
  • Gestational Carrier
Texas State Average
35.4%
View all 47 clinics in Texas →

What the CDC NASS Data Shows for IVFMD-Irving

IVFMD-Irving reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 685 total ART cycles, split between 24 fresh and 661 frozen embryo transfer cycles. The overall success rate, live births per cycle started, was 46.7%. That is 11.3 percentage points above the Texas state average of 35.4%.

Age remains the dominant variable in IVF outcomes. At IVFMD-Irving, patients under 35 saw a 57.3% success rate, compared with 43.8% for ages 35–37 and 22.0% for ages 38–40. Single embryo transfer (SET) was used in 57.3% of cycles, a metric ASRM associates with lower multi-pregnancy rates.

Service availability also affects which clinics fit which patients. IVFMD-Irving does not report donor egg services in the latest NASS filing and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary, PlainFertility is not affiliated with IVFMD-Irving or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.

Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer, a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.

Historical Success Rates

Year Total Cycles Overall Under 35 35–37 38–40 41–42
2022 685 46.7% 57.3% 43.8% 22.0% N/A
2021 647 32.2% 43.3% 35.7% 19.2% N/A
2020 505 N/A N/A N/A N/A N/A

Frequently Asked Questions

IVFMD-Irving's IVF success rate

IVFMD-Irving reports an overall IVF success rate of 46.7% across 685 reported cycles. Rates by age group vary, patients under 35 generally see higher success rates.

How should I interpret these success rates?

IVF success rates depend on patient age, diagnosis, embryo type, and treatment protocol. A clinic with a lower success rate may treat more complex cases. Always consult a board-certified reproductive endocrinologist who can evaluate your individual situation.

Where does this data come from?

All data is sourced from the CDC's National ART Surveillance System (NASS), which requires all ART clinics in the US to report their cycle outcomes annually under the Fertility Clinic Success Rate and Certification Act of 1992.

What is the difference between fresh and frozen IVF cycles?

Fresh cycles use embryos that have not been frozen, eggs are retrieved, fertilized, and transferred within the same treatment cycle. Frozen cycles use previously cryopreserved embryos. IVFMD-Irving reported 24 fresh cycles and 661 frozen cycles. Many clinics now favor frozen embryo transfers (FET) due to improved vitrification technology and comparable or higher success rates.

What does single embryo transfer (SET) percentage mean?

Single embryo transfer percentage indicates how often a clinic transfers just one embryo per cycle rather than multiple embryos. A higher SET rate generally reflects adherence to current ASRM guidelines aimed at reducing multiple pregnancies. IVFMD-Irving reports a SET rate of 57.3%. Higher SET rates typically mean fewer twins and triplets, which reduces pregnancy complications.

Does this clinic offer donor egg or gestational carrier services?

IVFMD-Irving does not currently list donor egg services and does offer gestational carrier (surrogate) services per the latest CDC NASS report. Contact the clinic directly to confirm current service availability and discuss whether these options are appropriate for your treatment plan.

Data source: CDC National ART Surveillance System (NASS). PlainFertility is not affiliated with the CDC or this clinic.

Data sourced from the CDC National ART Surveillance System (NASS). See our methodology for details. Retrieved and formatted by PlainFertility Editorial

Every figure on PlainFertility is rendered directly from CDC National ART Surveillance System source data, no number is typed in by an editor. This page draws directly on CDC National ART Surveillance System source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.